BG25090A3 - A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts - Google Patents

A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts

Info

Publication number
BG25090A3
BG25090A3 BG031843A BG3184375A BG25090A3 BG 25090 A3 BG25090 A3 BG 25090A3 BG 031843 A BG031843 A BG 031843A BG 3184375 A BG3184375 A BG 3184375A BG 25090 A3 BG25090 A3 BG 25090A3
Authority
BG
Bulgaria
Prior art keywords
benzomorphanes
tetrahydrofurfuryl
beta
salts
substituted
Prior art date
Application number
BG031843A
Other languages
Bulgarian (bg)
English (en)
Inventor
Herbert Merz
Adolf Langbein
Gerhard Walther
Klaus Stockhaus
Original Assignee
C.H.Boehringer Sohn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.H.Boehringer Sohn filed Critical C.H.Boehringer Sohn
Publication of BG25090A3 publication Critical patent/BG25090A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG031843A 1974-08-05 1975-08-02 A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts BG25090A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
BG25090A3 true BG25090A3 (en) 1978-07-12

Family

ID=5922448

Family Applications (3)

Application Number Title Priority Date Filing Date
BG030726A BG25088A3 (en) 1974-08-05 1975-08-02 A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts
BG031842A BG25089A3 (en) 1974-08-05 1975-08-02 A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts
BG031843A BG25090A3 (en) 1974-08-05 1975-08-02 A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts

Family Applications Before (2)

Application Number Title Priority Date Filing Date
BG030726A BG25088A3 (en) 1974-08-05 1975-08-02 A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts
BG031842A BG25089A3 (en) 1974-08-05 1975-08-02 A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts

Country Status (27)

Country Link
US (1) US3982005A (es)
JP (1) JPS60358B2 (es)
AT (1) AT348140B (es)
BE (1) BE832099R (es)
BG (3) BG25088A3 (es)
CA (1) CA1049008A (es)
CH (7) CH613963A5 (es)
CS (1) CS189717B2 (es)
DD (1) DD122685A5 (es)
DE (1) DE2437610A1 (es)
DK (1) DK138992C (es)
ES (6) ES452768A1 (es)
FI (1) FI63229C (es)
FR (1) FR2320096A2 (es)
GB (1) GB1513950A (es)
HU (1) HU177952B (es)
IE (1) IE42216B1 (es)
IL (1) IL47860A (es)
LU (1) LU73138A1 (es)
NL (1) NL7509249A (es)
NO (1) NO143460C (es)
PH (1) PH13687A (es)
PL (3) PL99838B1 (es)
RO (3) RO67390A (es)
SE (1) SE425392B (es)
SU (3) SU591147A3 (es)
ZA (1) ZA754997B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
JP5451611B2 (ja) 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックインヒビター
CA2704628C (en) 2007-11-16 2016-11-29 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja) 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター
US8598160B2 (en) 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
JP5538365B2 (ja) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
CL2009001058A1 (es) 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
PL2300461T3 (pl) 2008-05-01 2013-09-30 Vitae Pharmaceuticals Inc Cykliczne inhibitory dehydrogenazy 11beta-hydroksysteroidów 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2687525B1 (en) 2008-07-25 2015-09-23 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
AR078887A1 (es) * 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド 置換５、６及び７員複素環、そのような化合物を含有する医薬及びそれらの使用
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体
KR20230112134A (ko) 2020-11-26 2023-07-26 신에쓰 가가꾸 고교 가부시끼가이샤 실온경화성 오르가노폴리실록산 조성물 및 물품 그리고 가수분해성 오르가노실란 화합물 및 그 제조 방법
WO2023032745A1 (ja) 2021-09-03 2023-03-09 信越化学工業株式会社 オルガノポリシロキサン化合物、室温硬化性オルガノポリシロキサン組成物、及び物品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (es) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166804B2 (es) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
HU177952B (en) 1982-02-28
CH615678A5 (es) 1980-02-15
AT348140B (de) 1979-01-25
CH615679A5 (es) 1980-02-15
ATA523775A (de) 1978-06-15
DE2437610A1 (de) 1976-02-26
US3982005A (en) 1976-09-21
ES452766A1 (es) 1977-10-01
IL47860A (en) 1979-01-31
LU73138A1 (es) 1977-04-13
JPS5139673A (en) 1976-04-02
PL99819B1 (pl) 1978-08-31
CS189717B2 (en) 1979-04-30
IE42216L (en) 1976-02-05
SU587859A3 (ru) 1978-01-05
SU591147A3 (ru) 1978-01-30
ES452768A1 (es) 1977-10-01
SE425392B (sv) 1982-09-27
RO72735A (ro) 1982-09-09
DK138992C (da) 1979-04-30
DK138992B (da) 1978-11-27
NO143460C (no) 1981-02-18
JPS60358B2 (ja) 1985-01-07
ES452763A1 (es) 1977-10-01
CH616421A5 (es) 1980-03-31
FI63229B (fi) 1983-01-31
FI752211A (es) 1976-02-06
SU587858A3 (ru) 1978-01-05
BG25088A3 (en) 1978-07-12
CH613963A5 (es) 1979-10-31
CA1049008A (en) 1979-02-20
DK352875A (da) 1976-02-06
CH615680A5 (es) 1980-02-15
FR2320096B2 (es) 1978-09-01
NL7509249A (nl) 1976-02-09
FR2320096A2 (fr) 1977-03-04
RO72736A (ro) 1982-09-09
ES452764A1 (es) 1977-10-16
PH13687A (en) 1980-09-01
RO67390A (ro) 1981-06-30
PL99838B1 (pl) 1978-08-31
ZA754997B (en) 1977-04-27
DD122685A5 (es) 1976-10-20
GB1513950A (en) 1978-06-14
NO143460B (no) 1980-11-10
NO752731L (es) 1976-02-06
SE7508789L (sv) 1976-02-10
FI63229C (fi) 1983-05-10
ES452765A1 (es) 1977-10-16
IL47860A0 (en) 1975-11-25
PL99816B1 (pl) 1978-08-31
AU8364675A (en) 1977-02-10
BG25089A3 (en) 1978-07-12
CH615677A5 (es) 1980-02-15
CH616420A5 (es) 1980-03-31
BE832099R (fr) 1976-02-04
ES452767A1 (es) 1977-10-01
IE42216B1 (en) 1980-07-02

Similar Documents

Publication Publication Date Title
BG25090A3 (en) A method of obtaining 5,9-beta-substituted-2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts
BG25087A3 (en) A method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and their salts
BG24950A3 (en) A method of obtaining 1,3,4-trisubstituted-4-arilpiperidines
BG25082A3 (en) A method of obtaining 1-aroyl-2-arylamine-2-imidazole derivatives
PH11982A (en) Phenylalkylamines and salts thereof
BG25221A3 (en) A method of obtaining 2,6-disubstituted-2-phenylimine-imidazolidines and their salts
PH13405A (en) 11-aminoalkyl-pyridobenzodiazepinones and salts thereof
GR59201B (en) Preparation method of 8,8-disubstituted-6-methylergolines and related compounds
BG25518A3 (en) A method of obtaining xantain derivatives
BG23900A3 (en) Method of preparing 2-carbalcoxy-amino-benzimidazolyl-5(6)-sulfoacid phenylates
BG25199A3 (en) A method of obtaining derivatives of antibiotic a 204 i
BG25219A3 (en) A method of obtaining of substituted 2-phenylamineimidazolines-(2)and their additives with aciduous salts
JPS51125082A (en) Preparation method of 77 substitutedd88aminomethyll isoflavon derivatives
CS188251B2 (en) Method of producing 4-oxo-4h-pyrano-3,2-c-qunolin-2-carboxylic acids and salts thereof
BG25081A3 (en) A method of obtaining isohinolines
AU8208175A (en) Hexahydro-diazepino-indole derivatives and a process for their preparation
GB1523355A (en) 19,20-dinorprostanoic acids and salts thereof
JPS51118711A (en) Dividing method and compound
BG25223A3 (en) A method of obtaining 2,6,6-threemethyl-2-cyanomethyl-tetrahydropiran
BG25075A3 (en) A method of obtaining 1,2,4-triazol derivatives
BG25073A3 (en) A method of obtaining 3,7-dimethyl-3-hydroxy-6-oktennitryl
BG25085A3 (en) A method of obtaining n-(1'-alyl-2'-pyrolydylmethyl)-2-methoxy-4,5-azimidobenzamide
GR58594B (en) Preparation method of 2-halogenmethyl-1,4,-benzodiazepine
ZA754921B (en) 1-aryl-2-oxo-hexahydro-2,4,5,6,7,7a-indoles and acid addition salts thereof
HU173792B (hu) Sposob poluchenija novykh osnovnykh ehnol-ehfirov i ikh solej